William Pambrun

At Semper, we use liquidity to align the interests of private companies, team members and investors. We help forward-looking companies attract and retain builders by giving them real ownership of the value they create. We created Semper because the start-up world has changed. Staying private longer has given companies the freedom to grow on their own terms. But it has also significantly increased “time to liquidity” for the team members who create much of the value. Companies should be able to remain private while enabling those builders to benefit from the wealth they create - aligning incentives and encouraging greater growth. In order to do this, Semper has pioneered venture liquidity finance to help companies unlock their biggest asset – equity – for their other biggest asset – their team members. This ensures everyone stays aligned on long-term value creation. Companies may worry that recurring liquidity events will be complicated to manage- but they shouldn’t. Semper’s Team Liquidity Programs make it seamless for teams to have the opportunity to de-risk and benefit from their hard work, while keeping their company’s captable simple. We believe that team members are the unsung heroes behind many iconic companies’ success. Hence, our goal is to empower companies to share their wealth on fairer terms. This will create a virtuous loop in our ecosystem - putting more resources into the pockets of builders and supporting companies to innovate and grow. As entrepreneurs & investors who have built liquidity programs for a range of innovative companies, we understand what different stakeholders in this ecosystem need. That’s why Semper is so easy-to-use and reliable and why we focus on creating value for all stakeholders as well as being well-governed, properly regulated and backed by top investors.

We are an angel syndicate of Europes AI tech pioneers, experienced founders & operators, enthusiast tech buyers and supportive ecosystem players.

At Semper, we use liquidity to align the interests of private companies, team members and investors. We help forward-looking companies attract and retain builders by giving them real ownership of the value they create. We created Semper because the start-up world has changed. Staying private longer has given companies the freedom to grow on their own terms. But it has also significantly increased “time to liquidity” for the team members who create much of the value. Companies should be able to remain private while enabling those builders to benefit from the wealth they create - aligning incentives and encouraging greater growth. In order to do this, Semper has pioneered venture liquidity finance to help companies unlock their biggest asset – equity – for their other biggest asset – their team members. This ensures everyone stays aligned on long-term value creation. Companies may worry that recurring liquidity events will be complicated to manage- but they shouldn’t. Semper’s Team Liquidity Programs make it seamless for teams to have the opportunity to de-risk and benefit from their hard work, while keeping their company’s captable simple. We believe that team members are the unsung heroes behind many iconic companies’ success. Hence, our goal is to empower companies to share their wealth on fairer terms. This will create a virtuous loop in our ecosystem - putting more resources into the pockets of builders and supporting companies to innovate and grow. As entrepreneurs & investors who have built liquidity programs for a range of innovative companies, we understand what different stakeholders in this ecosystem need. That’s why Semper is so easy-to-use and reliable and why we focus on creating value for all stakeholders as well as being well-governed, properly regulated and backed by top investors.

At Inato, our mission is to bring clinical trials to each and every patient, regardless of who they are or where they live. Today, with 5% of sites running 70% of clinical trials, only patients with privileged access to these sites have an opportunity to participate in trials. We envision a world where it’s so easy to find and apply for the right trials that the other 95% of sites – often community-based research sites – can play a bigger role and accelerate research. By expanding access, we can make clinical trials more accessible, efficient, and inclusive. That’s why we’ve created a platform that connects global pharmaceutical companies with a broader range of research sites, while ensuring reliable high performance. Our exclusive site profiles, trial application & verification processes, and ongoing support help sites get selected and meet enrollment targets, while giving sponsors access to previously untapped patient populations. We’re seeing growing trust in community sites, faster timelines for sponsors and sites, increased patient accessibility, and diversified participation for more inclusive trials. Drug development is a challenging, intellectually complex, and rewarding endeavor. By working together to bring trial access into communities across the globe, we can more efficiently develop treatments that are safe and effective for everyone.